Skip to main content
Erschienen in: Herz 8/2018

09.10.2017 | Original articles

In-hospital mortality after acute STEMI in patients undergoing primary PCI

verfasst von: Dr. M. Ali, MD, S. A. Lange, MD, T. Wittlinger, MD, G. Lehnert, A. G. Rigopoulos, MD, M. Noutsias, MD

Erschienen in: Herz | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute myocardial infarction (AMI) is the main cause of global and in-hospital mortality in patients with cardiovascular diseases. We aimed to examine the association between the coronary artery involved and the in-hospital mortality in patients who underwent primary percutaneous coronary intervention (pPCI) after ST segment elevation myocardial infarction (STEMI).

Methods

The in-hospital mortality of STEMI patients who underwent pPCI was assessed at the Department of Cardiology, Harzklinik Goslar, Germany, which has no access to immediate mechanical circulatory support (MCS), between 2013 and 2017.

Results

We enrolled 312 STEMI patients, with a mean age of 67.1 ± 13.4 years, of whom 211 (68%) were male. In-hospital mortality was documented in 31 patients (10%). In-hospital mortality was associated with pre-hospital cardiopulmonary resuscitation (CPR; n = 39/12.5%), older age, lower systolic blood pressure, Killip class > 1, triple-vessel disease (each p < 0.0001), female gender (p = 0.0158), and with the localization of the treated culprit lesion in the left main coronary artery (LMCA; p = 0.0083) and in the ramus circumflexus (RCX; p = 0.0141).

Conclusion

In this monocentric cohort, all-cause in-hospital mortality of STEMI patients after pPCI was significantly higher in those patients with culprit lesions in the LMCA and in the RCX, which may prove to be a substantial novel risk factor for STEMI-related mortality. Increasing age and female gender may be interdependent risk factors for mortality in this patient population. Furthermore, our data highlight the importance of the availability of MCS options in pPCI centers for patients after CPR.
Literatur
1.
Zurück zum Zitat Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349(9063):1436–1442CrossRefPubMed Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349(9063):1436–1442CrossRefPubMed
2.
Zurück zum Zitat Tsai TH, Chua S, Hussein H et al (2011) Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Crit Care Med 39(3):436–442CrossRefPubMed Tsai TH, Chua S, Hussein H et al (2011) Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Crit Care Med 39(3):436–442CrossRefPubMed
4.
Zurück zum Zitat Zeymer U, Heuer H, Schwimmbeck P et al (2015) Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany. Herz 40(Suppl 1):27–35CrossRefPubMed Zeymer U, Heuer H, Schwimmbeck P et al (2015) Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany. Herz 40(Suppl 1):27–35CrossRefPubMed
6.
Zurück zum Zitat Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366(1):54–63CrossRefPubMed Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366(1):54–63CrossRefPubMed
7.
Zurück zum Zitat Simes RJ, Topol EJ, Holmes DR Jr. et al (1995) Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 91(7):1923–1928CrossRefPubMed Simes RJ, Topol EJ, Holmes DR Jr. et al (1995) Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 91(7):1923–1928CrossRefPubMed
8.
Zurück zum Zitat Stone GW, Grines CL, Browne KF et al (1995) Predictors of in-hospital and 6‑month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 25(2):370–377CrossRefPubMed Stone GW, Grines CL, Browne KF et al (1995) Predictors of in-hospital and 6‑month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 25(2):370–377CrossRefPubMed
9.
Zurück zum Zitat Yip HK, Wu CJ, Chang HW et al (2001) Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 87(10):1184–1188; A4CrossRefPubMed Yip HK, Wu CJ, Chang HW et al (2001) Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 87(10):1184–1188; A4CrossRefPubMed
10.
Zurück zum Zitat Seghieri C, Mimmi S, Lenzi J, Fantini MP (2012) 30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): an observational study using hospital discharge data. BMC Med Res Methodol 12:170CrossRefPubMedPubMedCentral Seghieri C, Mimmi S, Lenzi J, Fantini MP (2012) 30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): an observational study using hospital discharge data. BMC Med Res Methodol 12:170CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hochman JS, Buller CE, Sleeper LA et al (2000) Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1063–1070CrossRefPubMed Hochman JS, Buller CE, Sleeper LA et al (2000) Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1063–1070CrossRefPubMed
12.
Zurück zum Zitat Hasdai D, Topol EJ, Califf RM et al (2000) Cardiogenic shock complicating acute coronary syndromes. Lancet 356(9231):749–756CrossRefPubMed Hasdai D, Topol EJ, Califf RM et al (2000) Cardiogenic shock complicating acute coronary syndromes. Lancet 356(9231):749–756CrossRefPubMed
13.
Zurück zum Zitat Scholz KH, Maier SK, Jung J et al (2012) Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 5(8):848–857CrossRefPubMed Scholz KH, Maier SK, Jung J et al (2012) Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 5(8):848–857CrossRefPubMed
14.
Zurück zum Zitat Wong SC, Sanborn T, Sleeper LA et al (2000) Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1077–1083CrossRefPubMed Wong SC, Sanborn T, Sleeper LA et al (2000) Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1077–1083CrossRefPubMed
15.
Zurück zum Zitat Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296CrossRefPubMed Thiele H, Zeymer U, Neumann FJ et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296CrossRefPubMed
17.
Zurück zum Zitat Kalbfleisch H, Hort W (1977) Quantitative study on the size of coronary artery supplying areas postmortem. Am Heart J 94(2):183–188CrossRefPubMed Kalbfleisch H, Hort W (1977) Quantitative study on the size of coronary artery supplying areas postmortem. Am Heart J 94(2):183–188CrossRefPubMed
18.
Zurück zum Zitat Atie J, Brugada P, Brugada J et al (1991) Clinical presentation and prognosis of left main coronary artery disease in the 1980s. Eur Heart J 12(4):495–502CrossRefPubMed Atie J, Brugada P, Brugada J et al (1991) Clinical presentation and prognosis of left main coronary artery disease in the 1980s. Eur Heart J 12(4):495–502CrossRefPubMed
19.
Zurück zum Zitat Carasso S, Sandach A, Beinart R et al (2005) Echocardiography Working Group of the Israel Heart S. Usefulness of four echocardiographic risk assessments in predicting 30-day outcome in acute myocardial infarction. Am J Cardiol 96(1):25–30CrossRefPubMed Carasso S, Sandach A, Beinart R et al (2005) Echocardiography Working Group of the Israel Heart S. Usefulness of four echocardiographic risk assessments in predicting 30-day outcome in acute myocardial infarction. Am J Cardiol 96(1):25–30CrossRefPubMed
20.
Zurück zum Zitat Hillis GS, Moller JE, Pellikka PA et al (2005) Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction. Am Heart J 150(6):1268–1275CrossRefPubMed Hillis GS, Moller JE, Pellikka PA et al (2005) Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction. Am Heart J 150(6):1268–1275CrossRefPubMed
21.
Zurück zum Zitat Zmudka K, Zorkun C, Musialek P et al (2004) Incidence of ischemic mitral regurgitation in 1155 consecutive acute myocardial infarction patients treated with primary or facilitated angioplasty. Acta Cardiol 59(2):243–244PubMed Zmudka K, Zorkun C, Musialek P et al (2004) Incidence of ischemic mitral regurgitation in 1155 consecutive acute myocardial infarction patients treated with primary or facilitated angioplasty. Acta Cardiol 59(2):243–244PubMed
22.
Zurück zum Zitat Birnbaum Y, Chamoun AJ, Conti VR, Uretsky BF (2002) Mitral regurgitation following acute myocardial infarction. Coron Artery Dis 13(6):337–344CrossRefPubMed Birnbaum Y, Chamoun AJ, Conti VR, Uretsky BF (2002) Mitral regurgitation following acute myocardial infarction. Coron Artery Dis 13(6):337–344CrossRefPubMed
23.
Zurück zum Zitat Thompson CR, Buller CE, Sleeper LA et al (2000) Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1104–1109CrossRefPubMed Thompson CR, Buller CE, Sleeper LA et al (2000) Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 36(3 Suppl A):1104–1109CrossRefPubMed
24.
Zurück zum Zitat Becker RC, Gore JM, Lambrew C et al (1996) A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 27(6):1321–1326CrossRefPubMed Becker RC, Gore JM, Lambrew C et al (1996) A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 27(6):1321–1326CrossRefPubMed
25.
Zurück zum Zitat Sobkowicz B, Lenartowska L, Nowak M et al (2005) Trends in the incidence of the free wall cardiac rupture in acute myocardial infarction. observational study: experience of a single center. Rocz Akad Med Bialymst 50:161–165PubMed Sobkowicz B, Lenartowska L, Nowak M et al (2005) Trends in the incidence of the free wall cardiac rupture in acute myocardial infarction. observational study: experience of a single center. Rocz Akad Med Bialymst 50:161–165PubMed
26.
Zurück zum Zitat French PJ, Bijman J, Edixhoven M et al (1995) Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMP-dependent protein kinase II. J Biol Chem 270(44):26626–26631CrossRefPubMed French PJ, Bijman J, Edixhoven M et al (1995) Isotype-specific activation of cystic fibrosis transmembrane conductance regulator-chloride channels by cGMP-dependent protein kinase II. J Biol Chem 270(44):26626–26631CrossRefPubMed
27.
Zurück zum Zitat Crenshaw BS, Granger CB, Birnbaum Y et al (2000) Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 101(1):27–32CrossRefPubMed Crenshaw BS, Granger CB, Birnbaum Y et al (2000) Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 101(1):27–32CrossRefPubMed
28.
Zurück zum Zitat McNamara RL, Kennedy KF, Cohen DJ et al (2016) Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol 68(6):626–635CrossRefPubMed McNamara RL, Kennedy KF, Cohen DJ et al (2016) Predicting in-hospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol 68(6):626–635CrossRefPubMed
29.
Zurück zum Zitat Iqbal MB, Nadra IJ, Ding L et al (2017) Culprit vessel versus multivessel versus in-hospital staged intervention for patients with ST-segment elevation myocardial infarction and multivessel disease: stratified analyses in high-risk patient groups and anatomic subsets of nonculprit disease. JACC Cardiovasc Interv 10(1):11–23CrossRefPubMed Iqbal MB, Nadra IJ, Ding L et al (2017) Culprit vessel versus multivessel versus in-hospital staged intervention for patients with ST-segment elevation myocardial infarction and multivessel disease: stratified analyses in high-risk patient groups and anatomic subsets of nonculprit disease. JACC Cardiovasc Interv 10(1):11–23CrossRefPubMed
30.
Zurück zum Zitat Thiele H, Desch S, Piek JJ et al (2016) Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. Am Heart J 172:160–169CrossRefPubMed Thiele H, Desch S, Piek JJ et al (2016) Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial. Am Heart J 172:160–169CrossRefPubMed
Metadaten
Titel
In-hospital mortality after acute STEMI in patients undergoing primary PCI
verfasst von
Dr. M. Ali, MD
S. A. Lange, MD
T. Wittlinger, MD
G. Lehnert
A. G. Rigopoulos, MD
M. Noutsias, MD
Publikationsdatum
09.10.2017
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 8/2018
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-017-4621-y

Weitere Artikel der Ausgabe 8/2018

Herz 8/2018 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.